Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Markets

Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. NVS
stocks logo

NVS Valuation

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)

NVS Relative Valuation

NVS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NVS is overvalued; if below, it's undervalued.
Historical Valuation
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.00
P/B
Median3y
Median5y
0.00
FCF Yield
Median3y
Median5y

People Also Watch

FAQ

arrow icon

Is Novartis AG (NVS) currently overvalued or undervalued?

Novartis AG(NVS) is now in theFairzone, suggesting that its currentforward PEratio ofNaNis consideredFairlycompared with the five-year average of.The fair price of Novartis AG(NVS)is betweentoaccording to relative valuation methord.
arrow icon

What is Novartis AG (NVS) fair value?

NVS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price ofNovartis AG (NVS) is between to according to relative valuation methord.
arrow icon

How does NVS's valuation metrics compare to the industry average?

The average P/S ratio for NVS's competitors is 4.00, providing a benchmark for relative valuation. Novartis AG Corp (NVS) exhibits a P/S ratio of 3.98, which is -0.61% above the industry average. Given its robust revenue growth of 15.13%, this premium appearsunsustainable.
arrow icon

What is the current P/B ratio for Novartis AG (NVS) as of Apr 04 2025?

As of Apr 04 2025, Novartis AG (NVS) has a P/B ratio of . This indicates that the market values NVS at times its book value.
arrow icon

What is the current FCF Yield for Novartis AG (NVS) as of Apr 04 2025?

As of Apr 04 2025, Novartis AG (NVS) has a FCF Yield of%. This means that for every dollar of Novartis AG’s market capitalization, the company generates cents in free cash flow.
arrow icon

What is the current Forward P/E ratio for Novartis AG (NVS) as of Apr 04 2025?

As of Apr 04 2025, Novartis AG (NVS) has a Forward P/E ratio of . This means the market is willing to pay $ for every dollar of Novartis AG’s expected earnings over the next 12 months.
arrow icon

What is the current Forward P/S ratio for Novartis AG (NVS) as of Apr 04 2025?

As of Apr 04 2025, Novartis AG (NVS) has a Forward P/S ratio of . This means the market is valuing NVS at $ for every dollar of expected revenue over the next 12 months.
Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free